GLP-1 RAs: potential ocular adverse events in patients with and without T2DM

Reactions Weekly 2026

View at publisher

DOI: 10.1007/s40278-026-92171-y

Cited by: 0

References: 1

Fields of Study & Subjects

Drug-Induced Ocular Toxicity Diabetes Treatment and Management Retinal Diseases and Treatments

References 1